Choksi Laboratories Receives USFDA EIR for Central Laboratory in Indore
Choksi Laboratories Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 11:12 pm
Choksi Laboratories Receives USFDA EIR for Central Laboratory in Indore Choksi Laboratories Limited received an Establishment Inspection Report (EIR) from the USFDA on 3rd Nov'26, marking the formal closure of its inspection. The regulatory audit was previously conducted between 17th Aug'26 and 20th Aug'26 at the company's central laboratory facility located in Indore, Madhya Pradesh.
Original exchange filing (PDF)
More announcements from Choksi Laboratories Ltd
- Considered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September,2026 along with the Limited Review Report 路 14 Nov 2026
- 1. Considered and approved the Unaudited Financial Results for the Quarter and Half Year ended on 30th September, 2026 along with the Limited review report; 2. The Board has also discussed .... 路 14 Nov 2026
- Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve .... 路 14 Nov 2026
- We are enclosing herewith clarification on delay in submission with respect to proceedings of EGM 路 22 Oct 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for .... 路 19 Oct 2026
- The voting result along with the scrutinizer report the e-voting and remote e-voting held at EGM of the company held on 17.10.2026. 路 19 Oct 2026
- Summary of proceedings of EGM enclosed herewith 路 18 Oct 2026
- Extra-Ordinary General Meeting of the company is scheduled to be held on Saturday, 17th October, 2026 at 12:30 p.m. through video conferencing/OAVM to transact the business as set out in .... 路 24 Sept 2026
